The Pressure BioSciences (OTCMKTS:PBIO) stock could well be the one to track at this point in time following the sort of work that the company has managed to accomplish over the course of the past months.
Key Details
The company is involved in developing and selling pressure based instruments which are then used in a range of industries starting from cosmetics and agriculture to biotechnology and good and beverages. Yesterday, the company came into focus among investors after it announced its goals for 2022. It goes without saying that when a company makes such an announcement it is worth looking into.
Perhaps more importantly, it ought to be noted that the goals are not particularly lofty and Pressure BioSciences also announced yesterday that it believes that the goals are achievable.
The director of sales and marketing at the company, John B Hollister, noted that 2020 had been a highly challenging year for the company since most of the laboratories had to be closed down. However, the laboratories were opened up in 2021 and it led to a turnaround in Pressure Biosciences’ fortunes as the product revenues proved to be strong throughout the course of the 2021 financial year.
On the other hand, the Chief Executive Officer and President of the company, Michael T Schumacher noted that the number of instrument orders has grown at an impressive pace in recent times.
In addition to that, he noted that Pressure BioSciences had also managed to make considerable progress with regards to the commercial launch of the Ultra Shear Technology. It is a revolutionary new technology that could be deployed in a range of industries and hence, there is considerable excitement among the executives of the company. It may now be a good idea for investors to consider adding the stock to their watch lists and consider keeping an eye on the developments.
